Virginia Administrative Code
Title 11 - GAMING
Agency 10 - VIRGINIA RACING COMMISSION
Chapter 180 - MEDICATION
Section 11VAC10-180-60 - Medications and prohibited substances
Universal Citation: 1 VA Admin Code 10-180-60
Current through Register Vol. 41, No. 3, September 23, 2024
A. Medications and prohibited substances are divided into five classes. The classes are:
1. Class 1. Substances found in this class
have no generally accepted medical use in the racehorse and have a very high
pharmacological potential for altering the performance of a racehorse. These
substances should never be found in the horse's system through postrace testing
or in the possession of any holder of a permit within the enclosure of a horse
racing facility licensed by the commission. Such substances are potent
stimulants of the nervous system including opiates, opium derivatives,
synthetic opioids, psychoactive drugs, amphetamines and U.S. Drug Enforcement
Agency (DEA) Schedules I and II controlled substances.
2. Class 2. Substances in this class have a
high potential to affect the outcome of a race. Most are not generally accepted
as therapeutic agents in the racehorse. Many are products intended to alter
consciousness or the psychic state of humans and have no approved or indicated
use in the horse. Some, such as injectable local anesthetics, have legitimate
uses in equine medicine but should not be found in a racehorse through postrace
testing. The following groups of substances are in this class:
a. Opiate partial agonists or
agonist-antagonists;
b. Nonopiate
psychotropic drugs, which may have stimulant, depressant, analgesic or
neuroleptic effects;
c.
Miscellaneous substances that might have a stimulant effect on the central
nervous system (CNS);
d. Drugs with
prominent CNS depressant action;
e.
Antidepressant and antipsychotic drugs, with or without prominent CNS
stimulatory or depressant effects;
f. Muscle-blocking substances that have a
direct neuromuscular blocking action;
g. Local anesthetics that have a reasonable
potential for use as nerve-blocking agents (except procaine);
h. Other biological substances and snake
venoms or chemicals that may be used as nerve-blocking agents; and
i. Erythropoietin (Epogen), darbepoietin,
oxyglobin, hemopure, or other blood-doping agents.
3. Class 3. Substances found in this class
may or may not have an accepted therapeutic use in the horse but have a
potential to enhance performance, and their presence in the horse's system is
prohibited on race day. The following groups of substances are in this class:
a. Substances affecting the autonomic nervous
system that do not have prominent CNS effects, but that do have prominent
cardiovascular and respiratory system effects (bronchodilators are included in
this category);
b. Local
anesthetics that have nerve-blocking potential but also a high potential for
producing urine residue levels from a method of use not related to the
anesthetic effect of the substance (procaine);
c. Miscellaneous substances with mild
sedative action, such as the sleep-inducing antihistamines;
d. Primary vasodilating/hypotensive
agents;
e. Potent diuretics
affecting renal function and body fluid composition; and
f. Anabolic and/or androgenic steroids and/or
growth hormones other than boldenone, stanozolol, nandrolone, and testosterone,
which are classified elsewhere in this section.
4. Class 4. Substances in this class are
primarily therapeutic medications routinely used in racehorses. These may
influence performance, but generally have a more limited ability to do so. The
following groups of drugs are in this class:
a. Nonopiate substances that have a mild
central analgesic effect;
b.
Substances affecting the autonomic nervous system that do not have prominent
CNS, cardiovascular or respiratory effects:
(1) Substances used solely as topical
vasoconstrictors or decongestants;
(2) Substances used as gastrointestinal
antispasmodics;
(3) Substances used
to void the urinary bladder; and
(4) Substances with a major effect on CNS
vasculature or smooth muscle of visceral organs.
(5) Antihistamines that do not have a
significant CNS depressant effect (this does not include H1 blocking agents,
which are listed in Class 3).
c. Mineral corticoid substances;
d. Skeletal muscle relaxants;
e. Anti-inflammatory substances that may
reduce pains as a consequence of their anti-inflammatory actions, which
include:
(1) Nonsteroidal anti-inflammatory
drugs (NSAIDs);
(2) Corticosteroids
(glucocorticoids); and
(3)
Miscellaneous anti-inflammatory agents.
f. Boldenone, stanozolol, nandrolone, and
testosterone, individually but not in combination, at levels stipulated in
11VAC10-180-75.
g. Less potent diuretics;
h. Cardiac glycosides and antiarrhythmics
including:
(1) Cardiac glycosides;
(2) Anti-arrhythmic agents (exclusive of
lidocaine, bretylium and propranolol); and
(3) Miscellaneous cardiotonic
drugs.
i. Topical
anesthetics agents not available in injectable formulations;
j. Antidiarrheal agents; and
k. Miscellaneous substances including:
(1) Expectorants with little or no other
pharmacologic action;
(2)
Stomachics; and
(3) Mucolytic
agents.
5.
Class 5. Drugs in this class are therapeutic medications for which
concentration limits have been established as well as certain miscellaneous
agents. Included specifically are agents that have very localized action only,
such as anti-ulcer drugs and certain anti-allergenic drugs. The anticoagulant
drugs are also included.
B. Disciplinary actions.
1. In issuing penalties against individuals
found guilty of medication and drug violations a regulatory distinction shall
be made between the detection of therapeutic medications used routinely to
treat racehorses and those drugs that have no reason to be found at any
concentration in the test sample on race day.
2. The stewards or the commission may use the
most recent revision of the Association of Racing Commissioners International
(RCI) Uniform Classification Guidelines for Foreign Substances and the Multiple
Violations Penalty System as the guideline in the penalty stage of the
deliberations for a rule violation for any prohibited substance.
3. If a licensed veterinarian is
administering or prescribing a drug not listed in the RCI Uniform
Classification Guidelines for Foreign Substances, the identity of the drug
shall be forwarded to the commission veterinarian to be forwarded to RCI for
classification.
4. Any drug or
metabolite thereof found to be present in a pre-race or postrace sample that is
not classified in the most recent RCI Uniform Classification Guidelines for
Foreign Substances may be assumed to be an RCI Class 1 Drug and the trainer and
owner may be subject to those penalties as set forth in schedule "A" unless
satisfactorily demonstrated otherwise by the Racing Medication and Testing
Consortium, with a penalty category assigned.
5. Any permit holder of the commission,
including practicing veterinarians, found to be responsible for the improper or
intentional administration of any drug resulting in a positive test may be
subject to the same penalties set forth to the trainer.
6. Any veterinarian found to be involved in
the administration of any drug carrying the penalty category of "A" shall be
referred to the respective state licensing board of veterinary medicine for
consideration of further disciplinary action and/or license revocation. This is
in addition to any penalties issued by the stewards or the
commission.
7. Any person who the
stewards or the commission believe may have committed acts in violation of
criminal statutes shall be referred to the appropriate law-enforcement agency.
Administrative action taken by the stewards or the commission in no way
prohibits a prosecution for criminal acts committed, nor does a potential
criminal prosecution stall administrative action by the stewards or the
commission.
8. Pursuant to
11VAC10-60-70 E, all horses in the
care of a trainer who is suspended for more than 10 days must be transferred to
another trainer approved by the stewards. During the period of suspension the
suspended trainer shall have no communication with the new trainer, the new
trainers' staff, or the horse owner; shall not benefit financially from
transferred horses in his stable during the time of suspension; and shall not
be permitted on the grounds except with the permission of the
stewards.
Statutory Authority: § 59.1-369 of the Code of Virginia.
Disclaimer: These regulations may not be the most recent version. Virginia may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.